Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

MPH Health Care AG

93M1
Current price
22.40 EUR -0.8 EUR (-3.45%)
Last closed 22.60 EUR
ISIN DE000A289V03
Sector Financial Services
Industry Asset Management
Exchange XETRA Stock Exchange
Capitalization 103 799 931 EUR
Yield for 12 month +34.53 %
1Y
3Y
5Y
10Y
15Y
93M1
21.11.2021 - 28.11.2021

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medical­aesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company also focuses on therapies for cancer, HIV, rheumatology, and other chronic diseases. In addition, the company offers plastic and aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and specialist medical centres. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. Address: GrUenauer Strasse 5, Berlin, Germany, 12557

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

103.86 EUR

P/E ratio

0.86

Dividend Yield

5.34 %

Current Year

+7 310 383 EUR

Last Year

+6 919 612 EUR

Current Quarter

+85 013 056 EUR

Last Quarter

+7 224 973 EUR

Current Year

+127 226 183 EUR

Last Year

+6 873 984 EUR

Current Quarter

+85 013 056 EUR

Last Quarter

+34 436 478 EUR

Key Figures 93M1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 118 366 062 EUR
Operating Margin TTM 99.50 %
PE Ratio 0.86
Return On Assets TTM 25.94 %
PEG Ratio
Return On Equity TTM 44.96 %
Wall Street Target Price 103.86 EUR
Revenue TTM 119 449 532 EUR
Book Value 76.80 EUR
Revenue Per Share TTM
Dividend Share 1.21 EUR
Quarterly Revenue Growth YOY 24 556.80 %
Dividend Yield 5.34 %
Gross Profit TTM 13 649 519 EUR
Earnings per share 28.19 EUR
Diluted Eps TTM 28.19 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -31.00 %
Profit Margin 101.04 %

Dividend Analytics 93M1

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

74.00 %

Dividend History 93M1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.2
Ex Dividend Date 19.07.2024
Forward Annual Dividend Yield 4.88 %
Last Split Factor 1:10
Payout Ratio
Last Split Date 22.09.2020
Dividend Date

Stock Valuation 93M1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.8599
Forward PE
Enterprise Value Revenue 13.5409
Price Sales TTM 0.869
Enterprise Value EBITDA 0.8034
Price Book MRQ 0.3236

Financials 93M1

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 93M1

For 52 weeks

15.00 EUR 34.24 EUR
50 Day MA 24.56 EUR
Shares Short Prior Month
200 Day MA 24.72 EUR
Short Ratio
Shares Short
Short Percent